studi
cellpopul
heterogen
rang
biolog
system
virus
bacteri
isol
tumor
sampl
transform
recent
advanc
sequenc
throughput
highcoverag
afford
use
principl
identifi
rare
variant
popul
exist
ad
hoc
approach
frequent
fail
distinguish
true
variant
sequenc
error
report
method
lofreq
model
sequenc
runspecif
error
rate
accur
call
variant
occur
popul
use
simul
real
dataset
viral
bacteri
human
show
lofreq
nearperfect
specif
significantli
improv
sensit
compar
exist
method
effici
analyz
deep
illumina
sequenc
dataset
without
resort
approxim
heurist
also
present
experiment
valid
lofreq
two
differ
platform
fluidigm
sequenom
applic
call
rare
somat
variant
exom
sequenc
dataset
gastric
cancer
sourc
code
execut
lofreq
freeli
avail
http
sourceforgenetprojectslofreq
recent
advanc
sequenc
technolog
enabl
widespread
studi
heterogen
subpopul
cell
popul
migrat
away
consensu
sequenc
view
evolut
popul
perspect
applic
rang
biolog
system
character
viral
quasi
speci
intrahost
variat
bacteri
subpopul
subclon
evolut
cancer
precis
character
popul
structur
rare
subpopul
studi
fundament
analysi
popul
evolut
dynam
function
host
respons
drug
exposur
sever
recent
cancer
sequenc
studi
emphas
function
role
rare
subpopul
variant
aspect
tumor
growth
drug
resist
metastasi
need
comput
tool
studi
principl
high
throughput
massiv
parallel
sequenc
allow
sampl
even
rare
subpopul
sequenc
error
howev
complic
determin
true
variat
popul
sequenc
error
rate
known
highli
variabl
differ
significantli
technolog
run
lane
multiplex
genom
locat
well
substitut
type
approach
correct
studi
major
variantcal
method
focus
lowcoverag
human
resequenc
data
diploid
call
discret
frequenc
interest
ie
relat
set
method
tailor
call
diploid
genotyp
pool
sequenc
data
gener
applic
studi
rna
virus
provid
except
rule
rna
virus
high
mutat
rate
due
poor
miss
proofread
capabl
viral
rnadepend
dna
polymeras
high
replic
rate
result
intrahost
variat
implic
drug
treatment
strategi
genet
monitor
live
vaccin
method
use
studi
though
reli
ad
hoc
trim
filter
threshold
call
variant
limit
sensit
widespread
applic
need
manual
adjust
per
sampl
sequenc
run
recent
modelbas
approach
breseq
snver
potenti
sensit
gener
reli
simpl
binomi
model
tailor
accommod
bias
error
rate
sophist
approach
reli
phase
reduc
effect
sequenc
error
tailor
sequenc
recent
appli
viral
dataset
method
howev
directli
applic
technolog
run
larg
genom
sequenc
dataset
emerg
clinic
applic
use
sequenc
monitor
genom
state
cell
abil
detect
rare
variant
popul
edg
detect
limit
import
unfulfil
capabl
one
hand
increas
sensit
variant
caller
make
possibl
monitor
rare
import
subpopul
eg
cancer
stem
cell
mutat
hand
sensit
essenti
earli
detect
say
drugresist
subpopul
eg
antiretrovir
drug
hiv
set
ad
hoc
approach
lack
desir
adapt
robust
may
suffer
artifici
cap
sensit
variant
detect
precis
model
sequenc
error
essenti
push
sensit
limit
need
seek
address
work
present
sensit
robust
approach
call
singlenucleotid
variant
snv
highcoverag
sequenc
dataset
base
formal
model
bias
sequenc
error
rate
show
rigor
statist
test
done
effici
model
without
resort
approxim
thu
allow
exact
analysi
larg
genom
highcoverag
dataset
result
method
lofreq
adapt
automat
sequenc
run
positionspecif
sequenc
bias
call
snv
frequenc
lower
averag
sequenc
error
rate
dataset
lofreq
robust
sensit
specif
valid
use
sever
simul
real
dataset
viral
bacteri
human
two
experiment
platform
fluidigm
sequenom
result
appli
lofreq
call
rare
somat
snv
exom
sequenc
dataset
gastric
cancer
studi
dengu
viru
quasi
speci
treatment
clinic
studi
nucleosideanalog
drug
balapiravir
highlight
robust
versatil
approach
dengu
viru
sampl
sequenc
genom
institut
singapor
describ
descript
clinic
sampl
see
nguyet
et
al
sequenc
data
escherichia
coli
str
substr
clone
download
sequenc
read
archiv
sra
submiss
bp
read
map
wholegenom
exom
sequenc
data
gastric
cancer
taken
zang
et
al
librari
construct
singl
rtprimer
design
bind
specif
end
dengu
virus
genom
complementari
dna
cdna
synthesi
revertaid
tm
premium
first
strand
cdna
synthesi
kit
fermenta
st
leonrot
germani
use
primer
pair
design
gener
multipl
overlap
polymeras
chain
reaction
pcr
fragment
roughli
kb
size
pcr
perform
use
pfuultra
tm
ii
fusion
hs
dna
polymeras
stratagen
la
jolla
ca
usa
accord
manufactur
instruct
fragment
gel
extract
agaros
gel
prepar
tbe
buffer
concentr
measur
use
nanodrop
nd
spectrophotomet
thermo
fisher
scientif
waltham
usa
equal
concentr
dna
product
sampl
combin
fragment
peak
size
rang
bp
use
covari
covari
woburn
usa
shear
conditionsduti
cycl
intens
cycl
per
burst
time
fragment
sampl
purifi
use
qiagen
pcr
purif
kit
qiagen
valencia
ca
usa
fragment
product
qualitycheck
bioanalyz
dna
chip
agil
technolog
santa
clara
ca
usa
librari
prepar
nebnext
dna
sampl
prep
master
mix
kit
new
england
biolab
use
dna
sampl
underw
endrepair
atail
ligat
adapt
accord
manufactur
instruct
qualiti
check
ligat
product
bioanalyz
fragment
rang
bp
extract
agaros
gel
prepar
tae
buffer
clean
use
qiagen
gel
extract
kit
qiagen
qualitycheck
final
use
multiplex
sampl
prepar
oligonucleotid
kit
illumina
san
diego
ca
usa
sampl
underw
pcr
cycl
incorpor
indic
qualitycheck
use
bioanalyz
lightcycl
sybr
green
master
mix
roch
appli
scienc
indianapoli
usa
lightcycl
ii
realtim
thermal
cycler
roch
appli
scienc
accord
manufactur
instruct
studi
consist
reproduc
six
librari
replic
virus
creat
virus
grown
cell
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
extract
rna
underw
librari
prepar
describ
final
pcr
step
sampl
divid
six
reaction
index
multiplex
accordingli
dengu
viru
sampl
sequenc
genom
institut
singapor
illumina
gaii
sequenc
obtain
bp
read
base
call
done
casava
read
pass
illumina
chastiti
filter
casava
user
guid
remov
fluidigm
digit
array
ngc
cdna
use
construct
two
set
librari
parallel
pcr
duplic
sequenc
illumina
genom
analyz
ii
obtain
bp
pairedend
read
snv
call
replic
use
lofreq
snver
breseq
lowfrequ
snv
select
union
found
replic
frequenc
discord
call
method
bp
away
pcr
fragment
end
valid
fluidigm
digit
array
tm
fluidigm
san
francisco
ca
usa
cdna
quantif
perform
tecan
genio
micropl
detect
devic
tecan
inc
research
triangl
park
nc
usa
sampl
dilut
accordingli
taqman
assay
design
base
posit
snv
main
compon
sampl
prepar
premix
includ
taqman
gene
express
master
mix
appli
biosystem
life
technolog
foster
citi
ca
usa
ge
sampl
load
reagent
fluidigm
genespecif
assay
appli
biosystem
dilut
cdna
premix
transfer
prime
chip
load
use
integr
fluidic
circuit
control
mx
fluidigm
follow
manufactur
instruct
chip
run
biomark
tm
system
fluidigm
use
data
collect
softwar
data
extract
analyz
use
digit
pcr
analysi
softwar
fluidigm
snv
frequenc
determin
quadrupl
attempt
detect
sequenc
variant
within
pool
dengu
viru
genom
use
sequenom
massarray
iplex
primer
extens
platform
sequenom
san
diego
ca
usa
note
approach
expect
sensit
digit
pcr
correspondingli
use
measur
type
ii
error
rate
assay
sequenc
variant
design
multiplex
genotyp
step
compris
initi
pcr
reaction
amplifi
viral
genom
region
interest
follow
primer
extens
base
viral
genotyp
statu
size
extend
product
thu
repres
viral
genotyp
statu
resolv
mass
spectrometri
time
flight
total
clinic
sampl
cellcultur
sampl
assay
two
replic
posit
respect
primersampl
combin
moder
samplespecif
call
compar
sequencingbas
lofreq
call
assess
concord
gener
mutant
refseq
sequenc
randomli
mutat
posit
without
replac
thu
obtain
list
trueposit
snv
haplotyp
sequenc
simul
bp
read
use
metasim
error
rate
deriv
averag
qualiti
per
read
posit
clinic
sampl
coverag
level
replic
simul
qualiti
valu
ad
simul
fasta
file
produc
fastq
file
basecal
qualiti
abund
haplotyp
metasim
taxonomi
profil
set
accord
geometr
seri
multipl
factor
result
haplotyp
correspond
snv
frequenc
rang
lower
bound
clinic
sampl
took
six
dataset
highest
coverag
use
sensit
snvcall
modul
lofreqnq
see
call
variant
read
support
call
variant
remov
make
dataset
appear
clonal
retain
sequenc
error
consensu
genom
six
dataset
align
genbank
sequenc
also
use
read
map
determin
trueposit
snv
six
dataset
randomli
subsampl
pool
accord
geometr
seri
lead
rang
haplotypesnv
frequenc
total
coverag
test
detect
limit
variou
method
artifici
creat
short
align
variou
coverag
valu
control
count
nonrefer
base
ie
snv
detect
base
assign
uniform
qualiti
given
qualitycoverag
combin
record
minimum
number
nonrefer
base
need
call
snv
breseq
make
call
dataset
suspect
base
likelihood
ratio
test
use
background
frequenc
whole
align
meaning
artifici
short
dataset
model
sequenc
error
given
align
read
consensu
refer
lofreq
treat
base
column
aris
bernoulli
trial
success
referenceconsensu
base
failur
variant
base
trial
assum
independ
associ
sequenc
error
probabl
deriv
phredscal
qualiti
valu
q
base
p
exp
number
variant
base
k
column
n
base
given
poissonbinomi
distributiona
gener
binomi
distribut
bernoulli
trial
distinct
success
probabl
comput
exact
pvalu
null
model
employ
follow
recurs
formula
easi
deriv
first
principl
pr
n
xk
probabl
observ
k
variant
first
n
base
p
n
error
probabl
nth
base
pvalu
given
p
k
k
pr
n
xk
ie
sum
tail
probabl
mass
function
pmf
nn
naiv
recurs
base
equat
take
time
exponenti
n
dynam
program
approach
save
intermedi
result
allow
comput
pmf
n
time
n
larg
practic
aim
reduc
runtim
limit
comput
portion
intermedi
pmf
affect
final
pvalu
particular
easi
show
pr
n
xk
k
n
entri
n
n
k
k
k
nn
affect
final
pvalu
also
given
threshold
pvalu
p
k
k
pr
n
xk
n
pvalu
also
greater
shown
allow
comput
termin
prematur
column
align
nonvari
column
final
key
refin
lofreq
base
follow
recurs
n
p
k
k
pr
n
x
k
recurs
deriv
directli
equat
allow
lofreq
comput
pmf
k
k
addit
keep
track
n
use
equat
thu
worstcas
runtim
lofreq
reduc
kn
signific
gain
column
variant
base
note
maintain
numer
precis
arithmet
lofreq
done
logspac
comput
log
log
b
b
use
formula
log
log
log
b
log
avail
lofreq
take
phredscal
qualiti
valu
provid
sequenc
instrument
input
model
qualiti
calibr
describ
also
use
refin
valu
reduc
bia
variant
base
userdefin
threshold
default
error
rate
use
conserv
remov
base
qualiti
threshold
variant
base
assign
qualiti
absenc
userprovid
qualiti
valu
lofreq
model
error
rate
possibl
base
substitut
class
p
x
x
estim
use
expectationmaxim
em
approach
column
c
assum
come
one
two
model
either
refer
base
model
sequenc
error
r
variant
column
v
ie
z
c
r
v
train
phase
error
probabl
substitut
class
learnt
directli
data
expect
step
call
snv
use
binomi
test
bonferronicorrect
pvalu
current
error
probabl
maxim
step
updat
error
probabl
base
base
count
column
respect
substitut
class
call
snv
ie
refer
base
column
c
n
c
number
base
seen
column
c
assign
shown
maxim
likelihood
function
maxim
expect
step
iter
error
probabl
converg
final
snv
call
expect
step
use
converg
error
probabl
embas
approach
lofreqnq
faster
sensit
higher
falseposit
rate
data
shown
employ
qualiti
valu
miss
unreli
order
identifi
samplespecif
variant
say
somat
compar
tissu
b
lofreq
employ
follow
approach
variant
call
sampl
test
b
variant
call
b
lofreq
test
see
could
inadequ
read
coverag
b
use
binomi
test
snv
frequenc
variant
pass
test
report
specif
tosomat
analog
test
method
lofreq
allow
user
identifi
variant
posit
mark
signific
bia
strand
support
read
deriv
twotail
fisher
exact
test
hypothesi
variantbas
forward
revers
strand
count
come
distribut
consensu
base
user
choos
ignor
variant
high
strand
bia
low
pvalu
holmbonferroni
correct
multiplehypothesi
test
map
cellcultur
sequenc
read
use
refseq
sequenc
read
clinic
sampl
map
genbank
sequenc
respect
read
uniqu
map
use
razer
version
respect
refer
recognit
rate
set
allow
indel
twostep
map
approach
follow
recip
nguyet
et
al
use
consensu
deriv
initi
map
use
refer
second
step
gradual
lower
razer
ident
threshold
step
default
updat
map
kept
number
newli
map
read
increas
least
basequ
valu
recalibr
use
gatk
version
qualityscor
cycl
dinucleotid
covari
except
simul
sequenc
site
show
variat
least
variat
mark
known
variat
primer
posit
coverag
spike
exclud
snv
call
read
map
exclud
qualiti
recalibr
compar
frequenc
c
n
mutat
placebo
group
versu
drug
group
pair
sampl
tabl
call
snv
preand
postdos
sampl
use
lofreq
subtract
sum
snv
frequenc
predos
sampl
sum
postdos
sampl
normal
time
differ
number
cytosin
base
consensu
sequenc
result
number
measur
averag
mutat
rate
compar
drug
placebo
group
pair
use
mannwhitney
test
identifi
mutat
hotspot
use
scan
window
approach
scan
dengu
viru
genom
sampl
window
size
overlap
five
nucleotid
look
excess
snv
window
compar
genomewid
averag
binomi
test
bonferronicorrect
pvalu
coldspot
pool
snv
sampl
scan
window
minimum
size
deplet
snv
binomi
test
bonferronicorrect
pvalu
simul
read
gener
use
metasim
refseq
entri
refer
error
rate
number
read
set
observ
real
dataset
read
simul
real
dataset
uniqu
map
refseq
entri
use
bwa
result
averag
coverag
qualiti
recalibr
perform
real
dataset
way
done
dengu
data
real
dataset
assum
genet
clonal
true
rare
snv
detect
mitochondri
heteroplasmi
read
map
mitochondri
genom
extract
bam
file
stringent
remap
bwa
uniqu
cambridg
refer
allow
easi
comparison
mitomap
entri
follow
qualiti
recalibr
done
dengu
data
snv
call
use
lofreq
analysi
wholegenom
sequenc
data
appli
filter
rule
samtool
version
lofreq
allow
fair
comparison
specif
set
coverag
cap
remov
base
qualiti
samtool
default
correspond
error
rate
remov
predict
snv
qualiti
error
rate
remov
snv
three
present
window
bp
reduc
indelassoci
artifact
extra
strandbia
filter
appli
snp
call
valid
obtain
use
data
illumina
array
posit
predict
valu
ppv
comput
fraction
samtool
lofreq
call
array
posit
concord
snp
array
sensit
measur
fraction
genotyp
posit
correctli
call
variant
caller
exom
sequenc
data
somat
snv
call
lofreq
compar
call
made
use
samtoolsbas
pipelin
specif
somat
variant
report
variant
call
uniqu
tumor
normal
genotyp
call
samtool
differ
less
two
read
variant
genotyp
seen
normal
sampl
pvalu
somat
snv
call
produc
lofreq
bonferroni
correct
three
snp
present
window
bp
remov
reduc
indelassoci
artifact
done
samtool
call
well
goto
et
al
wright
et
al
order
enabl
comparison
method
describ
publicationswhich
chosen
repres
nonmodelbas
algorithmsw
reimplement
avail
part
lofreq
packag
use
snver
version
automat
determin
error
rate
wherea
origin
version
need
fix
userdefin
sequenc
error
threshold
snverindividualjar
modul
use
snv
call
number
haploid
set
altref
ratio
threshold
set
switch
filter
variant
frequenc
default
use
breseq
version
switch
polymorphismpredict
function
call
variant
note
breseq
endtoend
protocol
analysi
microbi
shortread
data
mani
featur
use
abil
predict
substitut
ran
full
breseq
pipelin
version
map
start
unmap
read
pars
snv
final
html
output
made
sens
use
breseq
standalon
variant
caller
eg
runtim
comparison
use
version
denot
breseq
lofreq
take
samtool
pileup
input
samtool
mpileup
version
default
samtool
appli
coverag
cap
set
suffici
high
avoid
filter
read
sampl
whenev
indel
allow
read
map
switch
samtool
baq
comput
b
snv
call
bonferronicorrect
pvalu
threshold
threshold
appli
call
somat
variant
binomi
test
unless
state
otherwis
remov
variant
posit
signific
strand
bia
holmbonferronicorrect
pvalu
lofreq
predict
simul
sequenc
dataset
gener
studi
download
http
collaborationsgisastaredusg
wilmalofreqpaperdata
sequenc
data
avail
soon
sequenc
read
archiv
benchmark
lofreq
exist
method
snver
breseq
goto
et
al
wright
et
al
construct
sever
silico
dataset
vari
characterist
particular
construct
dataset
simul
read
mimick
characterist
dengu
viru
sequenc
dataset
studi
see
materi
method
section
design
contain
haplotyp
rarest
repres
frequenc
dataset
allow
us
investig
perform
variou
method
function
sequenc
coverag
overal
heurist
approach
perform
poorli
term
sensit
goto
et
al
ppv
wright
et
al
modelbas
approach
snver
breseq
lofreq
perfect
ppv
therefor
perfect
specif
tabl
lofreq
also
sensit
method
perfect
specif
call
variant
frequenc
coverag
compar
snver
breseq
respect
expect
lower
coverag
sensit
fell
method
lofreq
continu
improv
result
snver
breseq
result
highlight
util
qualityawar
approach
lofreq
abl
exploit
inform
present
highcoverag
sequenc
dataset
call
variant
high
sensit
specif
order
close
mimic
bias
sequenc
read
coverag
base
qualiti
also
creat
simul
popul
dataset
use
real
sequenc
data
see
materi
method
section
snver
breseq
lofreq
perfect
specif
lofreq
consist
detect
highest
number
true
snv
frequenc
rang
figur
strike
aspect
result
even
snv
frequenc
lofreq
find
variant
miss
snver
breseq
provid
boost
sensit
rang
figur
fact
predict
made
breseq
snver
found
essenti
subset
lofreq
predict
figur
lofreq
increas
overal
sensit
compar
snver
breseq
respect
detect
limit
rare
variantcal
method
systemat
assess
gener
assumpt
variant
frequenc
lower
averag
error
rate
dataset
like
undetect
studi
aspect
evalu
method
dataset
control
coverag
valu
count
nonrefer
base
see
materi
method
section
result
show
lofreq
success
exploit
highcoverag
highqual
sequenc
data
call
variant
frequenc
low
condit
figur
contrast
modelbas
approach
snver
substanti
higher
detect
limit
unaffect
qualiti
data
figur
lofreq
abil
automat
tune
stringenc
thu
allow
adjust
local
variat
sequenc
qualiti
maxim
power
detect
variant
evalu
lofreq
variantcal
method
sever
larg
sequenc
dataset
viral
bacteri
human
particular
appli
method
six
technic
replic
cellcultur
isol
measur
robust
reproduc
result
see
materi
method
section
analysi
method
well
term
reproduc
snv
call
least
two
replic
lofreq
sensit
among
call
twice
mani
variant
averag
compar
snver
tabl
robust
lofreq
result
pool
data
nearli
superset
individu
call
supplementari
figur
robust
call
snver
tabl
analysi
suggest
sensit
major
limit
factor
variant
caller
addit
presenc
snv
seen
two
replic
six
replic
supplementari
figur
suggest
sequenc
coverag
may
bottleneck
fulli
captur
true
variant
popul
result
simul
real
dataset
suggest
lofreq
conserv
well
ultrasensit
variant
caller
character
falseposit
rate
lofreq
analyz
simul
well
real
data
e
coli
clone
coverag
see
materi
method
section
million
posit
e
coli
genom
provid
larger
test
case
simul
read
lofreq
report
falseposit
call
sequenc
data
breseq
lofreq
snver
report
potenti
falseposit
variant
respect
possibl
snv
fact
real
known
clonal
bacteri
popul
evolv
laboratori
condit
maintain
variat
even
equilibrium
condit
chemostat
nevertheless
result
suggest
three
method
conserv
lofreq
low
falseposit
rate
dataset
lofreq
design
applic
highcoverag
sequenc
viral
bacteri
genom
mind
gener
fast
enough
appli
larg
genom
lowcoverag
dataset
well
highlight
analyz
wholegenom
sequenc
data
two
gastric
adenocarcinoma
sampl
coverag
lofreq
compar
result
commonli
use
genotyp
caller
human
resequenc
dataset
samtool
use
snp
qualiti
threshold
ident
filter
rule
see
materi
method
section
interestingli
found
lofreq
predict
almost
perfect
superset
made
samtool
samtool
predict
share
lofreq
lofreq
predict
uniqu
overal
lofreq
similar
precis
samtool
ppv
method
dataset
higher
sensit
versu
dataset
measur
snp
array
see
materi
method
section
result
provid
basi
appli
lofreq
sensit
accur
call
somat
variant
pair
tumornorm
sequenc
dataset
discuss
later
note
comparison
meant
suggest
lofreq
use
genotyp
caller
case
samtool
similar
variant
caller
lofreq
runtim
scale
linearli
size
genom
runtim
increas
function
depth
coverag
similar
lofreq
fastest
ad
hoc
method
goto
et
al
wright
et
al
runtim
domin
time
pars
data
lofreq
faster
breseq
factor
order
magnitud
faster
snver
coverag
dengu
viru
genom
supplementari
figur
also
compar
naiv
version
comput
exact
pvalu
see
materi
method
section
lofreq
pruneddynamicprogram
approach
also
order
magnitud
faster
supplementari
figur
singl
processor
runtim
lofreq
roughli
min
dataset
coverag
dengu
viru
genom
size
kb
h
coverag
e
coli
genom
size
mbp
h
min
coverag
human
exom
size
mbp
note
parallel
implement
lofreq
sensit
ppv
report
averag
replic
sensit
measur
fraction
true
snv
correctli
call
ppv
measur
fraction
snv
call
correct
case
standard
deviat
present
result
breseq
standalon
variant
caller
indic
breseq
comparison
breseq
pipelin
unexpectedli
perform
poorli
dataset
straightforward
would
provid
runtim
improv
larg
genom
valid
lowfrequ
snv
report
variant
caller
challeng
task
one
attempt
publish
method
recent
avail
microfluid
digit
pcr
system
made
access
signific
cost
limit
technic
challeng
remain
largescal
valid
proofofprincipl
design
experi
fluidigm
digit
array
tm
fluidigm
base
randomli
chosen
snv
discord
call
lofreq
snver
breseq
two
replic
dengu
viru
sequenc
dataset
see
materi
method
section
supplementari
figur
strikingli
lofreq
predict
valid
experi
nine
nine
valid
call
figur
rarest
snv
detect
lofreq
frequenc
also
frequenc
estim
lofreq
within
experiment
predict
rang
case
contrast
breseq
correct
seven
nine
predict
snver
abl
correctli
call
two
higher
frequenc
variant
figur
despit
conserv
variant
caller
simul
dataset
snver
two
falseposit
call
dataset
addit
valid
design
experi
sequenom
massarray
iplex
platform
test
variant
posit
clinic
cellcultur
dengu
viru
sampl
see
materi
method
section
total
variant
positionsampl
combin
test
experi
call
made
sequenom
massarray
also
captur
result
lofreq
indic
type
ii
error
rate
lofreq
like
low
snver
also
detect
five
call
breseq
detect
four
five
call
result
highlight
fact
lofreq
call
snver
like
least
sensit
commonli
use
massspectrometrybas
goldstandard
valid
snv
highcoverag
exom
wholegenom
sequenc
dataset
match
tumor
normal
sampl
cancer
patient
increasingli
gener
character
cancerspecif
somat
mutat
could
play
drive
role
tumorigenesi
despit
known
heterogen
tumor
call
somat
variant
often
limit
major
cell
perform
use
ad
hoc
approach
addit
sinc
tumor
sampl
often
contamin
normal
tissu
abil
robustli
detect
somat
mutat
critic
particular
result
samtool
analysi
exom
sequenc
dataset
gastric
tumornorm
pair
sampl
zang
et
al
reveal
asymmetr
frequenc
distribut
somat
snv
call
suggest
sampl
contamin
lead
significantli
reduc
sensit
even
high
sequenc
coverag
supplementari
figur
reanalysi
dataset
lofreq
help
recov
full
distribut
figur
reveal
valu
systemat
approach
call
lowfrequ
somat
snv
even
goal
identifi
heterozyg
homozyg
variant
highcoverag
dataset
addit
also
extend
somat
snv
analysi
mitochondri
genom
coverag
two
wholegenom
sequenc
dataset
zang
et
al
particular
identifi
two
lowfrequ
somat
snv
c
g
nadh
dehydrogenas
patient
nonsynonym
list
mitomap
somat
mtdna
mutat
seen
divers
set
cancer
mutat
nadh
dehydrogenas
role
oxid
phosphoryl
mitochondria
could
potenti
play
import
role
analog
identifi
one
somat
snv
c
trna
ly
gene
patient
known
hotspot
mtdna
mutat
sever
variant
associ
myopathi
includ
one
posit
rare
heteroplasm
variat
previous
studi
target
resequenc
follow
ad
hoc
filter
detect
rule
shown
lead
irreproduc
result
shown
use
sensit
variant
caller
lowcoverag
wholegenom
sequenc
dataset
provid
new
approach
studi
phenomenon
sensit
robust
lofreq
allow
character
subtl
shift
viral
quasi
speci
highlight
capabl
analyz
dengu
viru
sequenc
dataset
drugtrial
studi
nucleosideanalog
balapiravir
sinc
put
mechan
action
drug
lead
mutat
cytosin
base
c
n
mutagen
inhibit
cmp
incorpor
dataset
provid
ideal
testb
studi
quasi
speci
dynam
dengu
viru
use
sampl
two
time
point
tabl
particular
import
conclus
origin
studi
result
indic
signific
chang
seen
frequenc
serotyp
mannwhitney
test
pvalu
provid
molecular
basi
vivo
conclus
studi
despit
detect
chang
viral
intrahost
variat
includ
increas
number
snv
later
time
point
expect
onesid
mannwhitney
test
pvalu
placebo
group
well
disappear
mutat
hotspot
see
materi
method
section
later
time
point
possibl
due
adapt
host
immun
respons
figur
leverag
snv
call
lofreq
systemat
determin
mutat
coldspot
hotspot
region
figur
see
materi
method
section
interestingli
featur
differ
substanti
two
serotyp
except
share
coldspot
membran
glycoprotein
precursor
protein
prm
known
critic
assembl
secret
flaviviru
virion
region
recent
shown
shown
germlin
variant
consist
distribut
around
expect
heterozyg
variant
somat
variant
shift
lower
frequenc
like
due
contamin
tumor
sampl
normal
stromal
tissu
note
samtoolsbas
somat
call
appear
clip
lower
frequenc
lofreq
call
symmetr
distribut
expect
sampl
analyz
collect
part
drugtrial
studi
nucleosideanalog
balapiravir
number
parenthes
report
total
number
sampl
sequenc
unparenthes
number
report
number
pair
preand
postdos
sampl
sequenc
conserv
across
flavivirus
though
conserv
readili
observ
align
complet
dengu
viru
genom
avail
genbank
supplementari
figur
comparison
clinic
cellcultur
sampl
also
reveal
share
hotspot
known
variabl
region
shown
dispens
replic
host
cell
type
valu
coldspot
hotspot
analysi
identifi
function
import
residu
also
seen
structur
perspect
figur
exampl
view
structur
methyltransferas
figur
first
group
coldspot
consist
contigu
residu
complet
enclos
bind
site
sadenosyllmethionin
sam
molecul
serv
methyl
donor
reaction
catalyz
cap
viral
mrna
second
group
coldspot
correspond
carboxyl
end
act
linker
region
connect
polymeras
domain
similarli
represent
coldspot
rnadepend
rna
polymeras
domain
figur
encompass
critic
gdd
catalyt
triad
also
templat
tunnel
viral
rna
substrat
enter
exit
replic
anoth
exampl
show
coldspot
hotspot
serin
proteas
helicas
delin
potenti
interact
surfac
key
resid
found
supplementari
figur
result
suggest
sequenc
character
intrahost
variat
rel
small
set
sampl
suffici
analysi
reveal
candid
drug
target
coldspot
well
fastevolv
region
viral
genom
hotspot
use
estim
haplotyp
divers
avoid
comput
complex
problem
avail
sensit
variant
caller
lofreq
thu
open
potenti
use
quasi
speci
footprint
approach
akin
phylogenet
footprint
reveal
function
import
region
viral
genom
well
exact
qualityawar
approach
employ
lofreq
statist
rigor
way
account
bias
sequenc
error
call
snv
principl
sequenc
technolog
independ
though
work
focus
illumina
dataset
complex
model
sequenc
error
construct
say
account
correl
adjac
base
would
technolog
specif
like
provid
modest
gain
sensit
sensitivityspecif
tradeoff
result
suggest
modelbas
approach
snver
breseq
provid
improv
ad
hoc
approach
signific
gain
sensit
possibl
without
loss
specif
use
qualityawar
approach
lofreq
note
lofreq
essenti
distinguish
true
variant
sequenc
error
also
serv
qualityawar
errorcorrect
modul
design
haplotyp
assembl
accommod
highcoverag
sequenc
dataset
inner
bar
mark
mutat
hotspot
red
coldspot
blue
deriv
intrahost
variat
call
lofreq
see
materi
method
section
height
hotspot
indic
often
hotspot
found
sqrt
count
wherea
height
coldspot
fix
coldspot
prm
share
serotyp
last
hotspot
window
sampl
found
predos
sampl
tabl
disappear
later
time
point
experiment
valid
result
confirm
rare
variant
discov
lofreq
inde
real
rarest
frequenc
lofreq
may
provid
sensit
boost
even
lowcoverag
wholegenom
sequenc
dataset
despit
reli
approxim
lofreq
fast
gener
enough
appli
highcoverag
human
wholeexom
genom
sequenc
dataset
thu
applic
beyond
analysi
lowfrequ
variant
viral
microbi
sequenc
dataset
abil
call
rare
somat
variant
particular
valuabl
genom
studi
tumor
heterogen
evolut
well
emerg
applic
tumor
monitor
sequenc
cellfre
dna
lofreq
sensit
help
detect
subtl
shift
cell
popul
thu
valuabl
sequencingbas
monitor
evolutionari
studi
viral
bacteri
cancer
sampl
abil
call
rare
variant
dictat
gener
sequenc
qualiti
read
coverag
lofreq
allow
user
exploit
local
variat
paramet
extens
simul
sort
depict
figur
employ
user
help
guid
experiment
design
goal
captur
snv
certain
frequenc
lofreq
base
calibr
qualiti
valu
commonli
gener
sequenc
data
feasibl
conserv
qualiti
valu
estim
averag
qualiti
valu
use
lofreqnq
see
materi
method
section
employ
accompani
loss
sensit
specif
respect
sequenc
qualiti
key
correctli
call
snv
indel
variant
like
influenc
align
qualiti
lofreq
variantcal
model
could
extend
indel
class
variant
probabl
error
variantsupport
read
encod
suitabl
comput
qualiti
valu
also
call
snv
lofreq
requir
uniqu
read
map
highqual
align
similar
variant
caller
call
rare
snv
region
nonuniqu
map
align
uncertainti
repres
signific
technic
challeng
potenti
direct
futur
extens
lofreq
supplementari
data
avail
nar
onlin
supplementari
figur
thank
author
snver
breseq
help
run
program
also
thank
dr
daniel
chin
han
bitter
lore
gruenbaum
erik
rasmussen
tom
chu
hoffmannla
roch
inc
well
studi
team
clinic
dengu
sampl
dr
swain
chen
shyam
prabhakar
provid
insight
comment
suggest
draft
articl
nucleosideanalog
ribavirin
triphosph
rtp
shown
blue
byproduct
sadenosyllmethionin
sam
transfer
methyl
group
sadenosyllhomocystein
sah
red
ballandstick
represent
coldspot
color
violet
first
group
coldspot
consist
contigu
residu
complet
enclos
bind
site
sam
sam
molecul
serv
methyl
donor
reaction
catalyz
methyltransferas
result
cap
viral
mrna
second
group
coldspot
correspond
carboxyl
end
methyltransferas
act
linker
region
connect
domain
polymeras
domain
b
surfac
represent
dengu
viru
rnadepend
rna
polymeras
pdb
access
number
gdd
catalyt
triad
color
red
wherea
coldspot
identifi
snv
analysi
color
violet
coldspot
includ
dengu
viru
rnadepend
rna
polymeras
gdd
catalyt
triad
also
part
templat
tunnel
viral
rna
substrat
enter
exit
replic
